iXell · Applications

Children and adolescents with diabetes

For a child with diabetes, monitoring is family work. Under 8, parents do everything; 8–14, supervised learning; 14+, the teenager is autonomous but the family stays informed. ISPAD sets specific targets for each stage.

Children and adolescents with diabetes
About the condition

Paediatric particularities

T1D is the most common form in children; T2D is occasional in obese adolescents. ISPAD 2022 sets HbA1c < 7.0% with minimal hypoglycemia. Particularities: growth, puberty hormone surges, school, sport, the fear of being different from peers — all of this shapes the SMBG plan.

Treatment

Protocol by age

1

0–6 years: parent does everything

4–6 readings/day: before meals, at bedtime, once a week at 03:00 (nocturnal hypo check). Targets are gentler — HbA1c < 7.5% because of unrecognised hypo risk.

2

7–12 years: supervised training

The child learns to lance themselves; the parent checks the reading and chooses the dose. By the end of the period — independent post-meal readings at school. A care plan goes to the school nurse.

3

13–17 years: autonomy + supervision

The teenager measures themselves and adjusts insulin. The parent reviews summary stats weekly — without pressure. The risk at this age is losing control because of rebellion against rules.

4

A school care plan is essential

Written plan with the principal and nurse: where the meter is stored, who helps with readings, what to do in a hypo, parent contacts. Device and strips — two sets (home + school).

iXell's role

Small blood sample size — critical for children

A small finger can't yield a large drop. iXell's 0.6 μL is among the lowest in class; easier for the child, shallower lancing. Button-eject of the strip — the parent doesn't touch used material. The 500-reading memory is enough to bring 2 months of data to a clinic visit.

Evidence

References

  1. ISPAD Clinical Practice Consensus Guidelines 2022

    Pediatric Diabetes · 2022

    On request
  2. T1D Exchange — real-world SMBG practice in paediatric T1D

    Foster N.C. et al. · Diabetes Technology & Therapeutics · 2019

    On request